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The immune recognition of cancer provides potential for
robust host control of tumors. Although the presence of
tumor-infiltrating lymphocytes (TILs) indicates an endo-
genous anti-tumor response, immune regulatory pathways
can subvert the effector phase and enable tumor escape.
Negative regulatory pathways include anergy, expression
of inhibitory receptors and ligands, metabolic dysregula-
tion, and recruitment of suppressive cell populations.
Recently, we have shown that the transcription factor
Early Growth Response 2 (Egr2) is critical in controlling
the anergic state by regulating the expression of DGK-a
and -ζ. Gene expression profiling and Egr2 ChIP-Seq
analysis revealed multiple Egr2-driven cell surface proteins
in T cell anergy, including LAG-3, CRTAM, and 4-1BB.
These data suggest that anergic cells may represent a
differential functional state with potential immune regula-
tory capacity. In this study we used Egr2 targets as well as
other previously defined molecules of T cell dysfunction,
PD-1 and TIM-3, to characterize T cells in the context of
the murine B16.SIY melanoma model. FACS and qPCR
revealed subpopulations of CD8+ TILs expressing Egr2 in
which PD-1 and LAG-3 are enriched. A major subset of
these cells also expresses 4-1BB, TIM-3, and CRTAM.
TCR repertoire analysis indicated TCRb skewing in the
marker-positive population suggesting oligoclonality, and
arguing that this cell subset might represent the T cells
with tumor specificity. Consistent with this notion, SIY-Kb
pentamer staining revealed that the vast majority of CD8+
T cells specific for this model antigen expressed LAG-3,
PD-1, and 4-1BB. In vitro stimulation of CD8+LAG-3
+PD-1+ double positive (DP) population revealed blunted
IL-2 transcription and proliferation compared to the
double negative (DN) population. Despite the inability to
make IL-2 and proliferate, these T cells produced high
levels of IL-10, IFN-g, CCL1, and CCL22, suggesting a
potential immunoregulatory function. Preliminary data
suggest that DP cells could suppress T cell proliferation in
vitro and promote tumor growth in vivo. Our results sug-
gest that the co-expression of LAG-3, PD-1, 4-1BB, and
perhaps CRTAM may identify a critical subpopulation of
dysfunctional TILs that are specific for tumor antigens
and contribute to an immune suppressive tumor microen-
vironment. Ultimately, inhibiting or agonizing receptors
on this subpopulation could have therapeutic relevance.
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